Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to 24.71%.

  • Nexgel's EBITDA Margin rose 20900.0% to 24.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.54%, marking a year-over-year increase of 329000.0%. This contributed to the annual value of 40.91% for FY2024, which is 441300.0% up from last year.
  • As of Q3 2025, Nexgel's EBITDA Margin stood at 24.71%, which was up 20900.0% from 22.05% recorded in Q2 2025.
  • In the past 5 years, Nexgel's EBITDA Margin ranged from a high of 22.05% in Q2 2025 and a low of 205.05% during Q1 2022
  • Moreover, its 5-year median value for EBITDA Margin was 92.93% (2024), whereas its average is 101.83%.
  • Per our database at Business Quant, Nexgel's EBITDA Margin skyrocketed by 5028900bps in 2021 and then tumbled by -102900bps in 2022.
  • Quarter analysis of 5 years shows Nexgel's EBITDA Margin stood at 166.42% in 2021, then decreased by -10bps to 182.57% in 2022, then surged by 38bps to 112.66% in 2023, then skyrocketed by 75bps to 27.66% in 2024, then increased by 11bps to 24.71% in 2025.
  • Its last three reported values are 24.71% in Q3 2025, 22.05% for Q2 2025, and 27.69% during Q1 2025.